Gene Symbol | PGR |
Entrez ID | 5241 |
Uniprot ID | P06401 |
Description | progesterone receptor |
Chromosomal Location | chr11: 101,029,624-101,130,524 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0006367 |
transcription initiation from RNA polymerase II promoter |
Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription. |
TAS |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
TAS |
BP |
GO:0010629 |
negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEP |
BP |
GO:0043401 |
steroid hormone mediated signaling pathway |
A series of molecular signals mediated by a steroid hormone binding to a receptor. |
IEA |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IDA |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
TAS |
CC |
GO:0005741 |
mitochondrial outer membrane |
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope. |
IEA |
MF |
GO:0000978 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II. |
IDA |
MF |
GO:0001077 |
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
IDA |
MF |
GO:0003677 |
DNA binding |
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
TAS |
MF |
GO:0003707 |
steroid hormone receptor activity |
Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function. |
IEA |
MF |
GO:0005496 |
steroid binding |
Interacting selectively and non-covalently with a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008270 |
zinc ion binding |
Interacting selectively and non-covalently with zinc (Zn) ions. |
IEA |
MF |
GO:0019899 |
enzyme binding |
Interacting selectively and non-covalently with any enzyme. |
IPI |
MF |
GO:0051117 |
ATPase binding |
Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP. |
IDA |
Domain ID | Description |
---|---|
IPR000128 |
Progesterone receptor |
IPR000536 |
Nuclear hormone receptor, ligand-binding domain |
IPR001628 |
Zinc finger, nuclear hormone receptor-type |
IPR001723 |
Nuclear hormone receptor |
IPR013088 |
Zinc finger, NHR/GATA-type |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04114 |
Oocyte meiosis |
KEGG |
hsa04914 |
Progesterone-mediated oocyte maturation |
KEGG |
hsa05224 |
Breast cancer |
KEGG |
WP34 |
Ovarian Infertility Genes |
WikiPathways |
WP170 |
Nuclear Receptors |
WikiPathways |
h_mPRPathway |
How Progesterone Initiates the Oocyte Maturation |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0001418 |
Adenocarcinoma |
C0014170 |
Endometrial Neoplasms |
C0014175 |
Endometriosis |
C0024667 |
Animal Mammary Neoplasms |
C0024668 |
Mammary Neoplasms, Experimental |
C0025286 |
Meningioma |
C0025500 |
Mesothelioma |
C1458155 |
Mammary Neoplasms |
Tissue | Cell Type |
---|---|
cervix, uterine |
glandular cells |
endometrium |
glandular cells |
endometrium |
cells in endometrial stroma |
fallopian tube |
glandular cells |
smooth muscle |
smooth muscle cells |
Database Name |
---|
DisGeNET |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
ZBTB17 |
7709 |
Q13105 |
0.52 |
ERBB2 |
2064 |
P04626 |
0.55 |
PIAS1 |
8554 |
O75925 |
0.55 |
PIAS3 |
10401 |
Q9Y6X2 |
0.55 |
SMARCE1 |
6605 |
Q969G3 |
0.56 |
ARID1A |
8289 |
O14497 |
0.56 |
TRIM24 |
8805 |
O15164 |
0.59 |
RBM39 |
9584 |
Q14498 |
0.59 |
RBM23 |
55147 |
Q86U06 |
0.59 |
PARP1 |
142 |
P09874 |
0.63 |
BPTF |
2186 |
Q12830 |
0.63 |
FKBP4 |
2288 |
Q02790 |
0.63 |
PPP5C |
5536 |
P53041 |
0.63 |
MAPK1 |
5594 |
P28482 |
0.63 |
STAT5A |
6776 |
P42229 |
0.63 |
STAT5B |
6777 |
P51692 |
0.63 |
DNAJC7 |
7266 |
Q99615 |
0.63 |
PRDM2 |
7799 |
Q13029 |
0.63 |
SPOP |
8405 |
O43791 |
0.63 |
STUB1 |
10273 |
Q9UNE7 |
0.63 |
NCOA2 |
10499 |
Q15596 |
0.63 |
SORBS1 |
10580 |
Q9BX66 |
0.65 |
SNW1 |
22938 |
Q13573 |
0.65 |
APEX2 |
27301 |
Q9UBZ4 |
0.65 |
COPS5 |
10987 |
Q92905 |
0.68 |
XRCC6 |
2547 |
P12956 |
0.70 |
XRCC5 |
7520 |
P13010 |
0.70 |
CDC25B |
994 |
P30305 |
0.75 |
HMGB1 |
3146 |
P09429 |
0.75 |
HMGB2 |
3148 |
P26583 |
0.75 |
POU2F1 |
5451 |
P14859 |
0.75 |
RELA |
5970 |
Q04206 |
0.75 |
SRC |
6714 |
P12931 |
0.76 |
UBR5 |
51366 |
O95071 |
0.76 |
KLF9 |
687 |
Q13886 |
0.77 |
KAT2B |
8850 |
Q92831 |
0.78 |
CUEDC2 |
79004 |
Q9H467 |
0.79 |
BATF3 |
55509 |
Q9NR55 |
0.80 |
CDK2 |
1017 |
P24941 |
0.82 |
FKBP5 |
2289 |
Q13451 |
0.84 |
SP1 |
6667 |
P08047 |
0.84 |
ESR1 |
2099 |
P03372 |
0.85 |
NCOA1 |
8648 |
Q15788 |
0.86 |
PGR |
5241 |
P06401 |
0.87 |
UBE3A |
7337 |
Q05086 |
0.88 |
NCOA3 |
8202 |
Q9Y6Q9 |
0.89 |
JDP2 |
122953 |
Q8WYK2 |
0.89 |
HSP90AA1 |
3320 |
P07900 |
0.49 |
CSNK2A1 |
1457 |
P68400 |
0.52 |
CCNA2 |
890 |
P20248 |
0.55 |
ANP32A |
8125 |
P39687 |
0.56 |
TAF1B |
9014 |
Q53T94 |
0.56 |
PRMT2 |
3275 |
P55345 |
0.59 |
BCAS2 |
10286 |
O75934 |
0.59 |
EP300 |
2033 |
Q09472 |
0.63 |
FGFR2 |
2263 |
P21802 |
0.63 |
GNAI1 |
2770 |
P63096 |
0.63 |
RNF4 |
6047 |
P78317 |
0.63 |
SGTA |
6449 |
O43765 |
0.63 |
SMARCA1 |
6594 |
P28370 |
0.63 |
NCOR1 |
9611 |
O75376 |
0.63 |
PRKDC |
5591 |
P78527 |
0.65 |
NR0B1 |
190 |
P51843 |
0.68 |
CCNA1 |
8900 |
P78396 |
0.72 |
MAGEA11 |
4110 |
P43364 |
0.73 |
POU2F2 |
5452 |
P09086 |
0.75 |
SMARCD1 |
6602 |
Q96GM5 |
0.75 |
TDG |
6996 |
Q13569 |
0.75 |
DAP3 |
7818 |
P51398 |
0.75 |
PIAS2 |
9063 |
O75928 |
0.75 |
DDX54 |
79039 |
Q8TDD1 |
0.75 |
BRCA1 |
672 |
P38398 |
0.80 |
STAT3 |
6774 |
P40763 |
0.84 |
NCOR2 |
9612 |
Q9Y618 |
0.90 |